US Stock MarketDetailed Quotes

AIM AIM ImmunoTech

Watchlist
  • 0.4282
  • +0.0217+5.34%
Close Apr 26 16:00 ET
  • 0.4282
  • 0.00000.00%
Post 19:20 ET
21.73MMarket Cap-713P/E (TTM)

About AIM ImmunoTech Company

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.

Company Profile

SymbolAIM
Company NameAIM ImmunoTech
Listing DateJul 19, 1996
Founded1966
CEOMr. Thomas K. Equels, Esq.
MarketAMEX
Employees28
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2117 SW Highway 484
CityOcala
ProvinceFlorida
CountryUnited States of America
Zip Code34473
Phone1-352-448-7797

Company Executives

  • Name
  • Position
  • Salary
  • Thomas K. Equels, Esq.
  • Chief Executive Officer, President, and Executive Vice Chairman
  • 2.66M
  • Robert Dickey, IV
  • Chief Financial Officer
  • --
  • Peter W. Rodino, III
  • Chief Operating Officer, General Counsel & Secretary
  • 793.48K
  • Dr. William M. Mitchell, M.D.,PhD
  • Chairman of the Board
  • 294.62K
  • Stewart L. Appelrouth
  • Independent Director
  • 294.62K
  • Nancy K. Bryan
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg